Key Points
- Review the natural history, mortality risks, and evidence-based clinical interventions for managing cardiovascular disease in patients with diabetes.
- Synthesis of landmark clinical trials, including UKPDS, HOPE, and DIGAMI, evaluating cardiovascular risk reduction strategies in diabetic cohorts.
- Review of prospective epidemiological investigations, including 20-year follow-up data from the Framingham study and findings from the Whitehall study.
- Coronary heart disease accounts for 75% of all deaths in diabetic individuals, with 33% of insulin-treated patients dying from coronary disease by age 50.
- Framingham study data demonstrated that diabetes increased the relative risk of coronary heart disease by 66% in men and 203% in women after adjusting for age, smoking, blood pressure, and cholesterol.
- Clinical trials demonstrated significant risk reduction through blood pressure management, converting enzyme inhibition, and acute insulin administration during myocardial infarction.
Structured PICO
PPopulationPatients with diabetes at risk for or with established cardiovascular disease
This review emphasizes the critical importance of aggressive cardiovascular risk management, including blood pressure control, ACE inhibition, and insulin therapy during myocardial infarction, for patients with diabetes.